AIMZ-938

N/A

Report date: 2024/11/08 16:44:51
NME

Base Information

Drug NameAIMZ-938
Drug Alias Namephenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonateAIMZ-938
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 Family 1 Subfamily A Member 1 modulators
TargetsCytochrome P450 Family 1 Subfamily A Member 1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaval University / Université Laval
China Registration ClassN/A

Develop Information

Active CompaniesLaval University / Université Laval
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A